IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.065
AS - Asia 1.058
EU - Europa 715
SA - Sud America 347
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.225
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.010
SG - Singapore 376
CN - Cina 361
BR - Brasile 292
IT - Italia 213
SE - Svezia 202
HK - Hong Kong 128
VN - Vietnam 102
DE - Germania 82
RU - Federazione Russa 56
FI - Finlandia 36
CA - Canada 35
GB - Regno Unito 28
PL - Polonia 24
IN - India 21
AR - Argentina 19
ZA - Sudafrica 18
EC - Ecuador 17
MX - Messico 16
NL - Olanda 14
FR - Francia 13
JP - Giappone 13
BD - Bangladesh 11
AT - Austria 10
ES - Italia 10
IE - Irlanda 9
IQ - Iraq 8
LT - Lituania 7
TR - Turchia 7
ID - Indonesia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CL - Cile 4
UA - Ucraina 4
AU - Australia 3
CM - Camerun 3
EG - Egitto 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
UY - Uruguay 3
A1 - Anonimo 2
BE - Belgio 2
BH - Bahrain 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
JM - Giamaica 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
VE - Venezuela 1
Totale 3.225
Salva come PNG Salva come JPEG
Città #
Dallas 279
Singapore 190
Ashburn 170
Hong Kong 126
Milan 108
Shanghai 87
Beijing 82
Hefei 52
New York 52
Ho Chi Minh City 48
Los Angeles 39
Princeton 39
Lawrence 38
São Paulo 34
Munich 26
Helsinki 25
Brescia 21
Rome 21
Moscow 19
Warsaw 19
Hanoi 16
Falkenstein 15
Nuremberg 15
Montreal 14
Stockholm 14
Denver 13
Johannesburg 13
Santa Clara 13
Tokyo 13
Atlanta 12
Cesano Boscone 11
The Dalles 11
Orem 10
Boston 9
Brooklyn 9
Dublin 9
Poplar 9
Amsterdam 8
Chennai 8
Guangzhou 8
Toronto 8
Belo Horizonte 7
Frankfurt am Main 7
Porto Alegre 7
Turin 7
Vienna 7
Bologna 6
Guayaquil 6
Haiphong 6
Houston 6
Lappeenranta 6
Rio de Janeiro 6
Washington 6
Boardman 5
Columbus 5
Council Bluffs 5
London 5
Manaus 5
Salvador 5
Shenzhen 5
Tashkent 5
Ancona 4
Ankara 4
Caxias do Sul 4
Chicago 4
Curitiba 4
Florianópolis 4
Manchester 4
Pune 4
Quito 4
Sorocaba 4
South San Francisco 4
Tianjin 4
Turku 4
Baghdad 3
Bergamo 3
Bogotá 3
Brasília 3
Busto Arsizio 3
Calgary 3
Campinas 3
Changsha 3
Charlotte 3
Erbil 3
Hangzhou 3
Hải Dương 3
Ipatinga 3
Joinville 3
Magnago 3
Melbourne 3
Mexico City 3
Mumbai 3
Muriaé 3
Phoenix 3
Pittsburgh 3
Querétaro 3
San Francisco 3
Taubaté 3
Topeka 3
Vancouver 3
Totale 1.960
Salva come PNG Salva come JPEG
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 149
The interferon landscape along the respiratory tract impacts the severity of COVID-19 100
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 99
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 96
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 92
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 91
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 90
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 90
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 86
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 85
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 83
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 80
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 79
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 75
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 75
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 72
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 71
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 69
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 68
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 67
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 67
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 67
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 66
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 65
Bacteriophages and Their Immunological Applications against Infectious Threats 65
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 64
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 61
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 61
The initial interplay between HIV and mucosal innate immunity 60
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 59
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 58
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 58
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 57
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 56
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 55
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 54
Role and potential therapeutic use of antibodies against herpetic infections 53
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 53
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 52
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 52
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 51
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 51
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 51
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 48
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 46
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 44
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 44
Viral Respiratory Pathogens and Lung Injury 42
Phage Therapy: An Alternative to Antibiotics 38
Next Generation Vaccines for Infectious Diseases 38
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 31
Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise 3
null 1
Totale 3.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 2 0 0 3 0 0
2021/202284 6 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024315 1 20 42 62 19 62 9 25 13 8 18 36
2024/2025892 81 20 13 35 33 94 158 170 90 63 58 77
2025/20261.673 233 279 373 423 305 60 0 0 0 0 0 0
Totale 3.388